We are live on ! Find out more
REGN icon

Regeneron Pharmaceuticals
REGN

371 hedge funds and large institutions have $17B invested in Regeneron Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 371 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more call options, than puts

Call options by funds: $300M | Put options by funds: $263M

Holders
371
Holders Change
+371
Holders Change %
–
% of All Funds
12.11%
Holding in Top 10
9
Holding in Top 10 Change
+9
Holding in Top 10 Change %
% of All Funds
0.29%
New
371
Increased
–
Reduced
–
Closed
–
Calls
$300M
Puts
$263M
Net Calls
+$37.1M
Net Calls Change
+$37.1M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$2.32B +$2.4B +10,298,359 New
Capital World Investors
2
Capital World Investors
California
$1.92B +$1.99B +8,529,729 New
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$1.42B +$1.47B +6,326,889 New
Wellington Management Group
4
Wellington Management Group
Massachusetts
$1B +$1.04B +4,449,456 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$962M +$996M +4,277,610 New
State Street
6
State Street
Massachusetts
$733M +$759M +3,260,060 New
Sands Capital Management
7
Sands Capital Management
Virginia
$706M +$731M +3,138,793 New
Artisan Partners
8
Artisan Partners
Wisconsin
$699M +$723M +3,106,428 New
JP Morgan Chase
9
JP Morgan Chase
New York
$650M +$673M +2,889,537 New
BIT
10
BlackRock Institutional Trust
California
$459M +$476M +2,041,986 New
BFA
11
BlackRock Fund Advisors
California
$342M +$354M +1,519,224 New
Goldman Sachs
12
Goldman Sachs
New York
$278M +$288M +1,236,398 New
Bank of New York Mellon
13
Bank of New York Mellon
New York
$243M +$251M +1,078,521 New
Invesco
14
Invesco
Georgia
$238M +$246M +1,056,898 New
Northern Trust
15
Northern Trust
Illinois
$228M +$236M +1,015,218 New
American Century Companies
16
American Century Companies
Missouri
$180M +$186M +800,624 New
Norges Bank
17
Norges Bank
Norway
$145M +$151M +646,436 New
PA
18
Pinnacle Associates
New York
$140M +$145M +623,202 New
Bank of America
19
Bank of America
North Carolina
$136M +$141M +606,015 New
Geode Capital Management
20
Geode Capital Management
Massachusetts
$117M +$121M +519,511 New
BG
21
BlackRock Group
United Kingdom
$117M +$121M +518,628 New
1832 Asset Management
22
1832 Asset Management
Ontario, Canada
$115M +$119M +513,020 New
Neuberger Berman Group
23
Neuberger Berman Group
New York
$105M +$109M +466,000 New
CCI
24
Columbus Circle Investors
$96.1M +$99.5M +427,218 New
Deutsche Bank
25
Deutsche Bank
Germany
$92.9M +$96.2M +413,300 New
1
2 3 4 5

REGN Hedge Fund Activity: Q2 2013 in Review

371 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Regeneron Pharmaceuticals (REGN) for Q2 2013, worth a combined $17B.

Buyers outnumbered sellers: 371 funds opened new REGN positions and 0 closed out — a net gain of 371 holders — while 0 added to existing stakes and 0 trimmed.

  • 371 institutional investors held Regeneron Pharmaceuticals (REGN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $17B of Regeneron Pharmaceuticals stock for Q2 2013.
  • 371 funds opened new Regeneron Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +371 holders.

Based on aggregated 13F filings for Q2 2013.